Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5206067
Max Phase: Preclinical
Molecular Formula: C88H74N8O16
Molecular Weight: 1499.60
Associated Items:
ID: ALA5206067
Max Phase: Preclinical
Molecular Formula: C88H74N8O16
Molecular Weight: 1499.60
Associated Items:
Canonical SMILES: COC(=O)c1c(C)nc(C)c(C(=O)OC)c1-c1ccc(-c2c3nc(c(-c4ccc(-c5c(C(=O)OC)c(C)nc(C)c5C(=O)OC)cc4)c4ccc([nH]4)c(-c4ccc(-c5c(C(=O)OC)c(C)nc(C)c5C(=O)OC)cc4)c4nc(c(-c5ccc(-c6c(C(=O)OC)c(C)nc(C)c6C(=O)OC)cc5)c5ccc2[nH]5)C=C4)C=C3)cc1
Standard InChI: InChI=1S/C88H74N8O16/c1-41-65(81(97)105-9)77(66(42(2)89-41)82(98)106-10)53-25-17-49(18-26-53)73-57-33-35-59(93-57)74(50-19-27-54(28-20-50)78-67(83(99)107-11)43(3)90-44(4)68(78)84(100)108-12)61-37-39-63(95-61)76(52-23-31-56(32-24-52)80-71(87(103)111-15)47(7)92-48(8)72(80)88(104)112-16)64-40-38-62(96-64)75(60-36-34-58(73)94-60)51-21-29-55(30-22-51)79-69(85(101)109-13)45(5)91-46(6)70(79)86(102)110-14/h17-40,93,96H,1-16H3/b73-57-,73-58-,74-59-,74-61-,75-60-,75-62-,76-63-,76-64-
Standard InChI Key: LYKOEKGPZZLHEU-GTFTZLNPSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1499.60 | Molecular Weight (Monoisotopic): 1498.5223 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Zattoni IF, Delabio LC, Dutra JP, Kita DH, Scheiffer G, Hembecker M, Pereira GDS, Moure VR, Valdameri G.. (2022) Targeting breast cancer resistance protein (BCRP/ABCG2): Functional inhibitors and expression modulators., 237 [PMID:35483322] [10.1016/j.ejmech.2022.114346] |
Source(1):